Skip to main
A

Agilent Technologies (A) Stock Forecast & Price Target

Agilent Technologies (A) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 47%
Buy 47%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Agilent Technologies is uniquely positioned in the market as a leading life science and diagnostic company with a diverse range of customers, including the growing biopharmaceutical, chemical, and advanced materials end markets. With operations in the US and China, Agilent's geographic diversity and strong product cycle momentum, along with its large exposure to drug manufacturing and minimal academic/government drag, make it a strong investment choice. Additionally, the company's recent earnings beat and raised guidance support its potential for continued growth.

Bears say

Agilent Technologies is facing significant challenges, including already high market optimism and a reliance on organic growth and margin expansion that may not be achievable due to external factors. Additionally, the company's exposure to cyclical industries and regions, namely China, puts it at risk for potential volatility and challenges in demand. While Agilent has a strong presence in the life sciences and diagnostics market, it faces sustainability challenges and diverging stakeholder expectations on climate and diversity measures. Overall, the company's financials and operations suggest a rocky outlook with potential downside risks in the future.

Agilent Technologies (A) has been analyzed by 17 analysts, with a consensus rating of Buy. 47% of analysts recommend a Strong Buy, 47% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Agilent Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Agilent Technologies (A) Forecast

Analysts have given Agilent Technologies (A) a Buy based on their latest research and market trends.

According to 17 analysts, Agilent Technologies (A) has a Buy consensus rating as of Sep 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $171.65, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $171.65, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Agilent Technologies (A)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.